Harvard Bioscience (HBIO) Profit After Tax Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 21.52% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -27.66% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 2.79% |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 19.70% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -0.24% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -64.60% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -67.40% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 8.70% |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn | -95.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95.79% |
| Dec 31, 2025 | -19.56% |
| Sep 30, 2025 | 28.76% |
| Jun 30, 2025 | -43.21% |
| Mar 31, 2025 | -94.14% |
| Dec 31, 2024 | -73.44% |
| Sep 30, 2024 | -204.55% |
| Jun 30, 2024 | -92.55% |
| Mar 31, 2024 | -91.44% |
| Dec 31, 2023 | -43.52% |
| Sep 30, 2023 | -4.11% |
| Jun 30, 2023 | 14.74% |
| Mar 31, 2023 | 28.82% |
| Dec 31, 2022 | -71.33% |
| Sep 30, 2022 | 6.43% |
| Jun 30, 2022 | 128.04% |
| Mar 31, 2022 | -39.31% |
| Dec 31, 2021 | -30.49% |
| Sep 30, 2021 | 12.76% |
| Jun 30, 2021 | 34.57% |